Actavis roots

Bangalore, India

API Development

Actavis 1956 - 1999

• 146 employees• Present in 1 country• EUR 57 million in sales

Actavis strong growth

Actavis today

Bangalore, India

API Development

Actavis in 2011

• The fourth largest generic player• EUR 1.7 billion in sales 2010• Present in over 40 countries• 1100 molecules on the market• 197 projects in the pipeline• 719 launches planned for 2011• 24 billion tablets/capsules manufactured 2010• Over 10,000 employees

Actavis a true global player

• International headquarters: Zug, Switzerland, 30 km from Zürich

• 29 nationalities in a staff of totally 150 people

• Senior team and strategic functions based in one place

Actavis top markets & growth driversBalkan Cluster and Montenegro

By divisions

Top growth marketsBalkan Cluster + Montenegro

Market Growth 1 Croatia 596,3%2 Slovenia 499,2%3 Montenegro 70,3%4 Albania 44,0%6 Bosnia &

Herzegovina18,3%

Serbia – Total MarketMAT July

7

ManufacturerRank

MAT Jul 2011EURO

MAT Jul 2011

Total Market 473 622 585

HEMOFARM 1 96 504 330

GALENIKA 2 48 392 092

ACTAVIS 3 26 626 241

Actavis manufacturing network

• Malta 

• Iceland 

• Bulgaria: Dupnitza 

• India: Alathur (finished 2013)

•  

• US: Elizabeth 

• UK: Barnstaple

• *Russia: Podolsk

• *China: Foshan 

• Indonesia: Jakarta 

• Serbia: Leskovac 

 

• Romania: Bucharest (oncology)

• Italy: Nerviano (oncology) 

• Bulgaria: Troyan (SSL) 

• USA: Lincolnton (SSL)

Launch sites High volume sites Regional sites Specialised sites

All sites comply with FDA or EU/GMP (Good Manufacturing Practice)* Local GMP standards

Actavis R&D sites

Elizabeth, NJ

SR, MR, SOD

Elizabeth, NJ

SOD, SR, MR

Fort Lauderdale, FL

SOD, SR, MR and othertechnically difficult

Fort Lauderdale, FL

SOD

products

Owning Mills, MD

SSL

Owing Mills, MD

SSL

Malta

Conventional SOD

Malta

Conventional SOD Romania

Oncology products, injectables and SOD

Romania

Oncology products, injectables and SOD

Chennai, India

Ticel Stabiling testing

Chennai, India

Stability testing centre

Bangalore, India

API Development

Jakarta, Indonesia

Local developement forSE-Asiaresearch organisation

Bangalore, India

API Development

Lotus Labs, a contract research organisation

Bangalore, India

Lotus, CROAPI, R&D

The 9 R&D sites are supported by regulatory centres in Iceland, Denmark, Bulgaria and the US, as well as by local regulatory units.

Iceland

SOD, SR, MR and conventional products

Iceland

SOD, SR, MR and conventional products

Actavis people

End 2010

Europe 7,208

Americas 1,165

MEA and Asia Pacific 833

Medis 82

India 983

Corporate 346

  10,617

Thank you!